Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$598,574
+$330,963 QoQ
Shares Held
16,928
+55.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
154,970 | $4,667,696 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
188,802 | $4,659,633 | |
| 3 | CRON |
Cronos Group Inc.
|
1,500,000 | $3,765,000 | |
| 4 | LQDA |
Liquidia Corp
|
40,595 | $1,532,055 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,345 | $1,390,538 | |
| 6 | VTRS |
Viatris Inc
|
102,186 | $1,380,532 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
50,735 | $1,146,611 | |
| 8 | ALKS |
Alkermes plc.
This page
|
16,928 | $598,574 |
All Filings in ALKS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $598,574 | 16,928 | Shares | Other | 2026-05-15 | |
| 2021-06-30 | $267,611 | 10,914 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||